Literature DB >> 7159402

Precursors in the biosynthesis of vasopressin and oxytocin in the rat. Characteristics of all the components in high-performance liquid chromatography.

R W Swann, C B Gonzalez, S D Birkett, B T Pickering.   

Abstract

A reverse-phase high performance liquid-chromatography (h.p.l.c.) protocol has been developed, whereby all the major known posterior-pituitary components that are derived from the processing of pro-oxytocin and pro-vasopressin can be separated one from another. Thus, in a single chromatographic step, it has been possible to separate vasopressin (VP), oxytocin (OT), oxytocin-neurophysin (rOT-Np), vasopressin-neurophysin (rVP-Np) and vasopressin-glycopeptide (rVP-GP) from acid extracts of the neurointermediate lobes of rat pituitary glands. All these peptides except rVP-GP were labelled in the neural lobe by 24h after a hypothalamic injection of [35S]cysteine, whereas all except VP were labelled by 24h after a similar injection of [3H]leucine. Three major labelled proteins were isolated from 20 min [35S]cysteine-injected rats when extracts of the supraoptic nucleus were subjected to Sephadex G-75 chromatography, h.p.l.c. and sodium dodecyl sulphate/polyacrylamide-gel electrophoresis. Immunoprecipitation with antisera raised against rat neurophysins, VP and OT revealed 21000- and 19000-mol.wt. common precursors to VP and rVP-Np and a 15000-mol.wt. common precursor to OT and rOT-Np. Some immunoreactive rVP-Np could occasionally be detected in the Vo of Sephadex G-75 chromatograms of Wistar rat supraoptic-nucleus extracts, but no evidence of [35S]neurophysin in this fraction was obtained from h.p.l.c. fingerprinting of its S-carboxymethylated tryptic digests. Radioimmunoassay for rVP-Np and rOT-Np revealed that about 70-80% of the total recovered immunoreactive neurophysin (IR-Np) in the supraoptic nucleus eluted from Sephadex G-75 and h.p.l.c. in the positions of rVP-Np and rOT-Np. Evidence is presented for an approx. 20000-mol.wt. rOT-Np in both Wistar and Brattleboro rats and for an approx. 20000-mol.wt. component in the Brattleboro rat that is recognized by vasopressin-neurophysin antisera.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159402      PMCID: PMC1153969          DOI: 10.1042/bj2080339

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Vasopressin biosynthesis. I. In vivo studies.

Authors:  H SACHS
Journal:  J Neurochem       Date:  1960-05       Impact factor: 5.372

Review 2.  Biosynthesis and release of vasopressin and neurophysin.

Authors:  H Sachs; P Fawcett; Y Takabatake; R Portanova
Journal:  Recent Prog Horm Res       Date:  1969

Review 3.  Immunological techniques for studies on the biogenesis of mitochondrial membrane proteins.

Authors:  S Werner; W Sebald
Journal:  Methods Biochem Anal       Date:  1981

4.  Identification of rat neurophysins: complete amino acid sequences of MSEL- and VLDV-neurophysins.

Authors:  M T Chauvet; J Chauvet; R Acher
Journal:  Biochem Biophys Res Commun       Date:  1981-11-30       Impact factor: 3.575

5.  The complete sequence of a novel human pituitary glycopeptide homologous to pig posterior pituitary glycopeptide.

Authors:  N G Seidah; S Benjannet; M Chrétien
Journal:  Biochem Biophys Res Commun       Date:  1981-05-29       Impact factor: 3.575

6.  In vivo biosynthesis of L-[35S]Cys-arginine vasopressin, -oxytocin, and -somatostatin: rapid estimation using reversed phase high pressure liquid chromatography.

Authors:  R E Franco-Bourland; J D Fernstrom
Journal:  Endocrinology       Date:  1981-10       Impact factor: 4.736

7.  Effects of small doses of colchicine on the components of the hypothalamo-neurohypophysial system of the rat.

Authors:  D C Parish; E M Rodríguez; S D Birkett; B T Pickering
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

8.  Nucleotide sequence of cloned cDNA encoding bovine arginine vasopressin-neurophysin II precursor.

Authors:  H Land; G Schütz; H Schmale; D Richter
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

9.  The Mr 80,000 common forms of neurophysin and vasopressin from bovine neurohypophysis have corticotropin- and beta-endorphin-like sequences and liberate by proteolysis biologically active corticotropin.

Authors:  M Lauber; P Nicolas; H Boussetta; C Fahy; P Béguin; M Camier; H Vaudry; P Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  The isolation of the native hormone-binding proteins from bovine pituitary posterior lobes. Crystallization of neurophysin-I and-II as complexes with [8-arginine]-vasopressin.

Authors:  M D Hollenberg; D B Hope
Journal:  Biochem J       Date:  1968-01       Impact factor: 3.857

View more
  5 in total

1.  Mutant vasopressin precursor in the endoplasmic reticulum of the Brattleboro rat. Ultrastructural evidence from individual "vasopressin" cells localized with the light microscope by use of a new gold/silver method for immunostain enhancement.

Authors:  S E Guldenaar; B T Pickering
Journal:  Cell Tissue Res       Date:  1988-09       Impact factor: 5.249

2.  Vasopressin gene is expressed at low levels in the hypothalamus of the Brattleboro rat.

Authors:  J A Majzoub; A Pappey; R Burg; J F Habener
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Non-neuronal cells of rat hypothalamus in dissociated cell culture. Evidence that neurophysin modulates growth and DNA synthesis of non-neuronal cells.

Authors:  R T Worley; B T Pickering
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Immunocytochemical evidence for the presence of a mutant vasopressin precursor in the supraoptic nucleus of the homozygous Brattleboro rat.

Authors:  S E Guldenaar; P Nahke; B T Pickering
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

5.  Structural organization of the rat gene for the arginine vasopressin-neurophysin precursor.

Authors:  H Schmale; S Heinsohn; D Richter
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.